Frequently Asked Questions
HOMEInvestor RelationsFrequently Asked Questions
- Please describe the founding of the company.
- Inspired by the latest biological research on RNA at Yale University in the United States in the early 2000s, Shingo Nakamura, the founder of our company, launched a project aiming to realize the discovery of small molecule drugs targeting messenger RNAs (mRNAs) in 2004 while he was working for Takeda Pharmaceutical Company Limited (hereinafter “Takeda”). He resigned from Takeda in 2011 with the research outcomes inherited from Takeda, and then redeveloped the fundamental technology to realize the said drug discovery, including statistical-mechanical theory and thermodynamic theory to study RNA structure based on the latest science, and computational software to apply these theories to the analysis. Shingo has also gained practical business experiences in pharmaceutical business, pharmaceutical manufacturing, venture business investment, and management. He established Veritas In Silico Inc. in November 2016 with the belief that providing “mRNA-targeted small molecule drug discovery” to a wide range of pharmaceutical companies will lead to solutions to common issues in the pharmaceutical industry.
For more details, see History.
- Where are you listed?
- Veritas In Silico Inc. was listed on the Tokyo Stock Exchange Growth Market on February 8, 2024.
- What is your securities code?
- It is 130A.
- When do you announce the financial results?
- Our fiscal year ends on December 31 every year. Financial results will be announced in February. Please refer to “IR Calendar” for quarterly financial results announcements.
- Where can I find the past financial results?
- Please refer to “IR Library” on this website.
- When is the record date for dividend payments?
- The record date for year-end dividends is December 31. If there are interim dividends, the record date for dividends is June 30.
- How many shares are in a trading unit?
- 100 shares. *One trading unit means the minimum number of shares for trading.
- What procedures are required for name transfers, changes of address, etc.?
- For stock-related procedures, please contact the securities company where you have opened your trading account.
- When are General Shareholders’ Meetings held?
- The Annual General Shareholders’ Meeting is basically held in late March every year. The date and place of the meeting of the Meeting shall be announced in early March to the shareholders as of December 31.
- How can I exercise my voting rights at the General Shareholders’ Meeting ?
- A notice of convocation of the General Shareholders’ Meeting and a form for exercising voting rights are sent to the shareholders listed on the register at the end of the record date of the General Shareholders’ Meeting (as of December 31 in the case of the General Shareholders’ Meeting). To exercise voting rights, you will be required to:
(1) bring the form for exercising voting rights and attend the meeting; or
(2) return the form for exercising voting rights after indicating your approval or disapproval of this form.
You can exercise your voting rights with either one of the methods shown above.
- Where can I request materials and make further inquiries?
- Please make inquiry from here.
